Shanghai Rendu Biotechnology Co. Ltd. A (688193) — Financial Flexibility Index
Shanghai Rendu Biotechnology Co. Ltd. A (688193) has a Financial Flexibility Index of 0.39x as of December 2025. Free cash flow of CN¥29.48 Million (operating CF CN¥22.41 Million minus capex CN¥7.07 Million) represents 0% of total liabilities (CN¥76.26 Million). Check Shanghai Rendu Biotechnology Co. Ltd. A (688193) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Rendu Biotechnology Co. Ltd. A Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Shanghai Rendu Biotechnology Co. Ltd. A across 7 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Shanghai Rendu Biotechnology Co. Ltd. A.
Annual Financial Flexibility Index for Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)
Year-by-year free cash flow to debt coverage for Shanghai Rendu Biotechnology Co. Ltd. A. Explore Shanghai Rendu Biotechnology Co. Ltd. A (688193) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | CN¥29.48 Million | CN¥22.41 Million | CN¥76.26 Million | ▼ -8.7% |
| 2024 | 0.42x | CN¥34.91 Million | CN¥24.39 Million | CN¥82.48 Million | ▲ +3.6% |
| 2023 | 0.41x | CN¥37.58 Million | CN¥17.19 Million | CN¥91.97 Million | ▲ +203.8% |
| 2022 | 0.13x | CN¥17.12 Million | CN¥-4.09 Million | CN¥127.34 Million | ▼ -84.9% |
| 2021 | 0.89x | CN¥80.92 Million | CN¥54.44 Million | CN¥90.86 Million | ▼ -21.2% |
| 2020 | 1.13x | CN¥108.15 Million | CN¥92.61 Million | CN¥95.75 Million | ▼ -40.0% |
| 2019 | 1.88x | CN¥68.49 Million | CN¥13.67 Million | CN¥36.41 Million | — |